Valuation: Sight Sciences, Inc.

Market Cap 301M 262M 244M 224M 423M 28.68B 430M 2.88B 1.13B 14.3B 1.13B 1.11B 47.17B P/E 2026 *
-9.24x
P/E 2027 * -12.3x
Enterprise Value 263M 229M 214M 196M 370M 25.09B 376M 2.52B 987M 12.51B 989M 967M 41.28B EV / Sales 2026 *
3.06x
EV / Sales 2027 * 2.74x
Free-Float
80.02%
Yield 2026 *
-
Yield 2027 * -
1 day+2.62%
1 week+7.08%
Current month+7.89%
1 month+3.56%
3 months+34.48%
6 months-7.27%
Current year-28.44%
1 week 5.05
Extreme 5.05
5.84
1 month 4.41
Extreme 4.41
5.84
Current year 3.38
Extreme 3.378
8.19
1 year 3.19
Extreme 3.19
9.24
3 years 1.04
Extreme 1.04
9.24
5 years 1.04
Extreme 1.04
40
10 years 1.04
Extreme 1.04
42.57
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 56 2009-12-31
Chief Executive Officer 51 2009-12-31
Director of Finance/CFO 43 2025-11-04
Director TitleAgeSince
Director/Board Member 51 2009-12-31
Director/Board Member 56 2009-12-31
Chairman 74 2016-12-31
Date Insider Type Main position Quantity % Market Cap.
7/6/26 Sell

Founder

-7,418 0.0136%
7/6/26 Sell

General Counsel

-12,733 0.0234%
7/2/26 Sell

Chief Financial Officer

-6,902 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
+2.62%+7.08%+63.54%-34.39% 301M
-1.69%-1.68%-18.83%-2.03% 185B
-1.53%-1.61%-4.64%+1.72% 111B
-1.12%-4.80%+3.61%+64.17% 60B
+2.63%+9.46%+43.51%+59.34% 53.9B
-0.79%+1.32%-5.80%-37.76% 46.9B
+0.40%+0.35% - - 34.22B
-0.65%+15.90%+13.77%-27.91% 32.95B
-0.63%+2.82%+45.35%-7.62% 24.49B
-0.05%+0.75%+1.59%+2.68% 22.67B
Average -0.05%+5.45%+15.79%+2.02% 57.17B
Weighted average by Cap. -0.73%+3.77%-0.18%+7.51%

Financials

2026 *2027 *
Net sales 86.08M 74.82M 69.85M 64.12M 121M 8.21B 123M 824M 323M 4.09B 323M 316M 13.5B 95.76M 83.22M 77.7M 71.33M 134M 9.13B 137M 916M 359M 4.55B 360M 352M 15.01B
Net income -34.77M -30.22M -28.22M -25.9M -48.84M -3.31B -49.69M -333M -130M -1.65B -131M -128M -5.45B -28.69M -24.94M -23.28M -21.37M -40.3M -2.73B -41M -275M -108M -1.36B -108M -105M -4.5B
Net Debt -37.61M -32.68M -30.51M -28.01M -52.82M -3.58B -53.74M -360M -141M -1.79B -141M -138M -5.9B -38.44M -33.41M -31.19M -28.63M -53.99M -3.66B -54.93M -368M -144M -1.83B -144M -141M -6.03B
Logo Sight Sciences, Inc.
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, and the SION Surgical Instrument is a bladeless, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is used by adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the cause of dry eye disease.
Employees
186
Date Price Change Volume
26-08-04 US$5.675 +2.62% 13,459
26-08-03 US$5.530 +5.13% 178,034
26-07-31 US$5.260 0.00% 95,835
26-07-30 US$5.260 -1.50% 82,967
26-07-29 US$5.340 +0.75% 136,275
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
5.530USD
Average target price
8.400USD
Spread / Average Target
+51.90%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SGHT Stock